{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:06:38Z","timestamp":1789203998852,"version":"build-2803163510"},"reference-count":39,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2007,4,13]],"date-time":"2007-04-13T00:00:00Z","timestamp":1176422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[2007,7]]},"abstract":"<jats:p><jats:bold>Summary:\u2002<\/jats:bold><jats:italic>Purpose:<\/jats:italic>Epileptic seizure results from excessive discharge in a population of hyperexcitable neurons. A number of studies help to document the effects of active oxygen free radical scavengers such as \u03b1\u2010tocopherol or ascorbic acid (vitamin C). In the present study, we examined the effects of ascorbic acid, at the six different doses, on penicillin\u2010induced epileptiform activity.<\/jats:p><jats:p><jats:italic>Methods:<\/jats:italic>A single microinjection of penicillin (2.5 \u03bcl, 500 units, intracortically) into the left sensorimotor cortex induced epileptiform activity within 2\u20135 min, progressing to full seizure activity lasting \u223c3\u20135 h. In the first set of experiments, 30 min after penicillin injection, six different doses of ascorbic acid (25, 50, 100, 200, 400, or 800 mg\/kg) were administered intraperitoneally (IP). The other group of animals received the effective dose of ascorbic acid (100 mg\/kg, IP) for 7 days. Ascorbic acid administration was stopped 24 h before penicillin treatment. Another group of rats received the effective dose of ascorbic acid (100 mg\/kg, IP) 30 min before penicillin treatment. In the second set of experiments, the lipid peroxidation (MDA) and reduced glutathione (GSH) levels of brain were measured in the control, control + ascorbic acid, penicillin, and penicillin + ascorbic acid groups.<\/jats:p><jats:p><jats:italic>Results:<\/jats:italic>Ascorbic acid, at the low dose (50, 100 mg\/kg, 30 min after penicillin injection), decreased both the frequency and amplitude of penicillin\u2010induced epileptiform activity in rats. Ascorbic acid, at intermediate doses (200, 400 mg\/kg, 30 min after penicillin injection), decreased the frequency of epileptiform activity without changing the amplitude. Ascorbic acid, at the lowest dose (25 mg\/kg) and highest dose (800 mg\/kg) (30 min after penicillin injection), did not change either the frequency or amplitude of epileptiform activity. Ascorbic acid, at the low dose (100 mg\/kg) was the most effective dose in changing the frequency and amplitude of penicillin\u2010induced epileptiform activity. Pretreatment with ascorbic acid (100 mg\/kg) 30 min before penicillin treatment caused a significant delay in the onset of penicillin\u2010induced epileptiform activity. Pretreatment with ascorbic acid (100 mg\/kg) for 7 days did not change the latency of epileptiform activity. The most effective dose of ascorbic acid (100 mg\/kg) prevented both the decrease in GSH level and the increase in lipid peroxidation level (MDA) occurring after penicillin\u2010induced epileptiform activity.<\/jats:p><jats:p><jats:italic>Conclusions:<\/jats:italic>These data indicate that ascorbic acid has neuroprotective activity against penicillin\u2010induced epileptiform electrocorticogram activity.<\/jats:p>","DOI":"10.1111\/j.1528-1167.2007.01080.x","type":"journal-article","created":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T16:52:11Z","timestamp":1176915131000},"page":"1388-1395","source":"Crossref","is-referenced-by-count":61,"title":["The Effects of Ascorbic Acid on Penicillin\u2010induced Epileptiform Activity in Rats"],"prefix":"10.1111","volume":"48","author":[{"given":"Mustafa","family":"Ayyildiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sule","family":"Coskun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdal","family":"Agar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,4,13]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(99)02269-6"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1515\/JBCPP.1996.7.3.179"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/00207450390245207"},{"key":"e_1_2_6_5_1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1684\/j.1950-6945.2002.tb00490.x","article-title":"Epilepsy and neuroprotection: an illustrated review","volume":"3","author":"Arzimanoglou A","year":"2002","journal-title":"Epileptic Disorders"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(03)00265-5"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0300-483X(85)90008-3"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2005.09.012"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00221-006-0425-7"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0188-0128(98)00013-X"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0891-5849(94)00218-9"},{"key":"e_1_2_6_12_1","first-page":"520","article-title":"Lipid peroxidation and cellular damage in extrahepatic tissues of bromobenzene intoxicated mice","volume":"123","author":"Casini A","year":"1986","journal-title":"American Journal of Pathology"},{"key":"e_1_2_6_13_1","first-page":"2223","volume-title":"Harrison's principles of internal medicine","author":"Dichter MA","year":"1994"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199907130-00009"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0891-5849(92)90073-P"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(00)00041-5"},{"key":"e_1_2_6_17_1","first-page":"23","article-title":"Small molecule antioxidant defences in human extracellular fluids","volume":"5","author":"Frei B","year":"1992","journal-title":"Current Communications in Cell & Molecular Biology"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2004.04537.x"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.CRJ04004X"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FPJ04032X"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(90)90510-6"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(98)00002-1"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(96)00362-9"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2003.01772.x"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511663314.003"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/54.6.1119s"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2004.07.012"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2001.00659.x"},{"key":"e_1_2_6_29_1","first-page":"448","article-title":"Compatibility of penicillin and ascorbic acid injection","volume":"33","author":"Pfeifer HJ","year":"1976","journal-title":"American Journal of Hospital Pharmacy"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(95)00494-B"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0891-5849(90)90096-2"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200307010-00015"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113759"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2005.02.030"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1990.tb05354.x"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(79)90091-2"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00310622"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0891-5849(92)90005-2"},{"key":"e_1_2_6_39_1","first-page":"51","volume-title":"Epilepsy: a window to brain mechanisms","author":"Wyler AR","year":"1980"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-4680(02)00009-3"}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1528-1167.2007.01080.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1528-1167.2007.01080.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T20:50:37Z","timestamp":1736974237000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1528-1167.2007.01080.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,13]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["10.1111\/j.1528-1167.2007.01080.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1528-1167.2007.01080.x","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,13]]}}}